United States · FDA National Drug Code directory
Mifepristone
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 43393-001_539725c1-189c-1934-e063-6294a90ac3c0
- Product NDC
- 43393-001
- Form
- TABLET
- Composition / generic term
- MIFEPRISTONE
- Labeler
- GenBioPro, Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20190501
- Source listing expiry
- 20271231
Source-listed ingredients
- MIFEPRISTONE — 200 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 6 CARTON in 1 PACKAGE (43393-001-06) / 1 BLISTER PACK in 1 CARTON / 1 TABLET in 1 BLISTER PACK (43393-001-01) · 43393-001-06
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →